Search results for 26

Anti-RPN10 | 26S proteasome regulatory subunit RPN10 antibodies, Agrisera, AS19 4266

Anti-RPN1a 26S proteasome regulatory subunit RPN1a antibodies, Agrisera, AS19 4264

26S Proteasome Complex Subunit SEM1 (SEM1) Antibody (FITC), Abbexa, abx305304

SHFM1 Antibody (FITC) is a Rabbit Polyclonal against SHFM1 conjugated to FITC. The product of this gene has been localized within the split hand/split foot malformation locus SHFM1 at chromosome 7. It has been proposed to be a candidate gene for the autosomal dominant form of the heterogeneous limb developmental disorder split hand/split foot malformation type 1. In addition, it has been shown to directly interact with BRCA2. It also may play a role in the completion of the cell cycle.

26S Proteasome Regulatory Subunit 6B (PSMC4) Antibody (HRP), Abbexa, abx317153

26S Proteasome Regulatory Subunit 6B (PSMC4) Antibody (HRP) is a Rabbit Polyclonal against 26S Proteasome Regulatory Subunit 6B (PSMC4) conjugated to HRP. The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. This gene encodes a member of the triple-A family of ATPases that is a component of the 19S regulatory subunit and plays a role in 26S proteasome assembly. The encoded protein interacts with gankyrin, a liver oncoprotein, and may also play a role in Parkinson's disease through interactions with synphilin-1. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.

Splicing Factor U2AF 26 kDa Subunit (U2AF1L4) Antibody, Abbexa, abx320855

U2AF1L4 Antibody is a Rabbit Polyclonal against U2AF1L4.

Solute Carrier Family 26 Member 6 (SLC26A6) Antibody, Abbexa, abx339392

SLC26A6 Antibody is a Rabbit Polyclonal against SLC26A6.

Splicing Factor U2AF 26 kDa Subunit (U2AF1L4) Antibody, Abbexa, abx431759

U2AF1L4 Antibody is a Goat Polyclonal antibody against U2AF1L4.

Anti-MEF2B antibody [EPR22193-26] - BSA and Azide free, Abcam, AB242347

ab242347 is the carrier-free version of ab242058 . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Conjugation ready Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications. Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold. Compatibility This product is compatible with the Maxpar ® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar ® is a trademark of Fluidigm Canada Inc.

26S Proteasome Regulatory Subunit 10B (PSMC6) Antibody (HRP), Abbexa, abx304987

26S Proteasome Regulatory Subunit 10B (PSMC6) Antibody (HRP) is a Rabbit Polyclonal against 26S Proteasome Regulatory Subunit 10B (PSMC6) conjugated to HRP. The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes one of the ATPase subunits, a member of the triple-A family of ATPases which have a chaperone-like activity. Pseudogenes have been identified on chromosomes 8 and 12.

Proteasome 26S Subunit, Non ATPase 2 (PSMD2) Antibody, Abbexa, abx001625

PSMD2 Antibody is a Rabbit Polyclonal antibody against PSMD2. The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes one of the non-ATPase subunits of the 19S regulator lid. In addition to participation in proteasome function, this subunit may also participate in the TNF signalling pathway since it interacts with the tumor necrosis factor type 1 receptor. A pseudogene has been identified on chromosome 1. Alternative splicing results in multiple transcript variants of this gene.